Alnylam Pharmace. Stock
Alnylam Pharmace. Stock
There is an upward development for Alnylam Pharmace. compared to yesterday, with an increase of €3.55 (2.130%).
Currently there is a rather positive sentiment for Alnylam Pharmace. with 3 Buy predictions and 0 Sell predictions.
With a target price of €200.00 there is a slightly positive potential of 17.302% for Alnylam Pharmace. compared to the current price of €170.50.
So far the community has only identified positive things for Alnylam Pharmace. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Alnylam Pharmace. in the next few years
Pros
2
Could be worthwhile Investment >10% per year
Cons
0
-
Performance of Alnylam Pharmace. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 2.130% | 5.148% | 21.485% | 59.989% | 58.186% | 144.735% | - |
| Sage Therapeutics Inc. | -0.810% | -3.208% | -1.532% | -45.475% | -51.209% | - | - |
| Mirati Therapeutics Inc. | 0.450% | -0.325% | -19.002% | -35.227% | -32.011% | - | - |
| Arena Pharmaceuticals Inc | -3.140% | -3.774% | 6.250% | -8.108% | -18.400% | 35.530% | 233.116% |
Comments
Other discussions about Alnylam Pharmace. Stock
Trading Alnylam Pharmace.
Trading Alnylam Pharmace.
